Alnylam Pharmaceuticals
ALNY
#626
Rank
$31.80 B
Marketcap
$246.58
Share price
1.06%
Change (1 day)
32.41%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Total assets

Total assets on the balance sheet as of September 2024 : $4.20 Billion USD

According to Alnylam Pharmaceuticals 's latest financial reports the company's total assets are $4.20 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Alnylam Pharmaceuticals - Total assets on balance sheet (from 2003 to 2024)

Total assets by year

Year Total assets Change
2023-12-31$3.82 B7.99%
2022-12-31$3.54 B-2.66%
2021-12-31$3.64 B6.93%
2020-12-31$3.40 B42.25%
2019-12-31$2.39 B52.09%
2018-12-31$1.57 B-21.05%
2017-12-31$1.99 B57.96%
2016-12-31$1.26 B-8.92%
2015-12-31$1.38 B28.43%
2014-12-31$1.07 B156.72%
2013-12-31$0.42 B46.26%
2012-12-31$0.28 B1.99%
2011-12-31$0.28 B-28.31%
2010-12-31$0.39 B-18.31%
2009-12-31$0.48 B-13.21%
2008-12-31$0.55 B12.33%
2007-12-31$0.49 B105.74%
2006-12-31$0.24 B144.04%
2005-12-31$98.34 M48.77%
2004-12-31$66.1 M87.89%
2003-12-31$35.18 M118.38%
2002-12-31$16.11 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
$1.13 B-72.89%๐Ÿ‡บ๐Ÿ‡ธ USA
$37.44 B 790.41%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.59 B-14.39%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.25 B-46.35%๐Ÿ‡บ๐Ÿ‡ธ USA
$93.76 M-97.77%๐Ÿ‡บ๐Ÿ‡ธ USA
$103.52 B 2,361.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$139.09 B 3,207.82%๐Ÿ‡ซ๐Ÿ‡ท France
$41.75 B 893.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel